New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients Jan. 10, 2019 By Diane Mapes / Fred Hutch News Service How do you make cancer clinical trials available to more patients? A new study published today...
CYPRESS currently enrolling children aged 6-9 at clinical sites throughout the U.S. and Canada SightGlass Vision, Inc., a medical device company developing spectacle lenses to slow the progression of nearsightedness or myopia in children, today announced its...
Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 women in the BLOC pivotal clinical trial received the FemBloc® permanent contraceptive treatment. FemBloc is a...
ChemomAb, a clinical-stage biopharmaceutical company focused on the development of novel therapies for fibrotic-inflammatory diseases, announced dosing of the first patient in a Phase 1b repeated dose clinical trial with CM-101 in non-alcoholic fatty liver disease...
Advicenne (Paris:ADVIC) (Euronext: ADVIC), specializing in the development of adult and pediatric therapeutic products for the treatment of orphan renal and neurological diseases, announces today that it has received authorization from the Belgian health authority...
Email
Text